SCHEMBL25567671

SCHEMBL25567671

CCOC(=O)C(C)(C)c1ccc(NC(=O)[C@H](C)N)cc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.53
TAAR1 Q96RJ0 2/20 0.48
LTA4H P09960 1/20 0.46
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
RAB9A P51151 1/20 0.44
HTT P42858 1/20 0.43
LMNA P02545 2/20 0.42
XIAP P98170 1/20 0.42
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TSHR P16473 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10679282 0.81 RORC (0.62) RORCHTTLMNAMAPTSMN1; SMN2
SCHEMBL3484906 0.80 RORC (0.53) RORCLMNAMAPTSMN1; SMN2TSHR
Hydrochloric Acid SCHEMBL8139012 0.79 RORC (0.52) RORCLMNAMAPTSMN1; SMN2TSHR
SCHEMBL25534917 0.79 PDE2A (0.44) RORCHTTLMNASMN1; SMN2TSHR
SCHEMBL31323285 0.77 RAB9A (0.71) CA1CA2RAB9AHTTMAPT
SCHEMBL10169477 0.75 LMNA (0.49) RORCRAB9AHTTLMNASMN1; SMN2
SCHEMBL12273496 0.75 RORC (0.52) RORCRAB9ALMNAMAPTSMN1; SMN2
SCHEMBL1767942 0.75 RORC (0.52) RORCRAB9ALMNAMAPTSMN1; SMN2
SCHEMBL397134 0.75 CYP1A2 (0.53) RORCRAB9ALMNAMAPTSMN1; SMN2
SCHEMBL6279399 0.74 CNR2 (0.58) RORCRAB9AHTTMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159465-A1 IMMUNOMODULATOR HITGEN INC. (CN) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159465-A1 IMMUNOMODULATOR IL2, IL17A, IL2RA RORC 18/4885TAAR1 3071/4885LTA4H 467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.